BKDT — Stock Film
STOCK FILMSCENE 1/12BKDT · $77.60
Stock Expert AI presents
BKDT
Brookdale Senior Living Inc. 7
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Brookdale Senior Living Inc. 7. What it actually does.

Operates independent living communities for seniors who require minimal assistance. Provides assisted living services for seniors who need help with daily activities. Now — the numbers.

on the stock market since 2022
24K employees
$1.2B market value
WHERE DOES THE MONEY COME FROM?
95%Health Care, Resident Service
Health Care, Resident ServiceReimbursement Costs, Managed Communities 4%Management Service <1%
95% of all revenue comes from a single line: Health Care, Resident Service.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$3.2B
The loss that same year:
$262.7M
For every $1 it earns, the company spends $1.1.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are moving sideways.

No real growth (4% a year). Red columns mark years that ended in a loss.

$2.7B
2021
2022
2023
2024
$3.2B
2025
In the vault right now:
$279.1M
DEBT: $1.3B
At this pace, that money lasts about 1.1 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
0.4×

This company is not turning a profit, so the market is pricing its sales instead: 0.4× for every dollar of annual revenue.

No analyst target is on record for this company.

What executives did with their own stock over the last 12 months:
4 buy9 sell

Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 28% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Sales are holding up

The company sells $3.2B a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $3.50 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
The losses continue

A loss of $262.7M against $3.2B in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts about 1.1 years. After that, the company needs to find new money.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution.

This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film